Ares Capital Corporation (ARCC) - 10-Q Summary
Business Context and Reporting Period
Company: Ares Capital Corporation (ARCC)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2007
Business Overview: ARCC is a closed-end, non-diversified management investment company regulated as a Business Development Company (BDC) under the Investment Company Act of 1940. It invests primarily in first and second lien senior loans, mezzanine debt, and equity in private U.S. middle-market companies. The company is externally managed by Ares Capital Management LLC.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2007 | Six Months Ended June 30, 2006 |
|---|---|---|
| Total Investment Income | $87.1 million | $50.7 million |
| Net Investment Income | $43.9 million | $21.0 million |
| Net Realized Gains (Losses) | ($7.5 million) | $24.5 million |
| Net Unrealized Gains (Losses) | $20.7 million | ($14.9 million) |
| Net Increase in Stockholders' Equity | $57.2 million | $30.5 million |
| Earnings Per Share (Basic & Diluted) | $0.93 | $0.80 |
| Total Assets | $1.70 billion | $1.35 billion (Dec 31, 2006) |
| Total Debt Outstanding | $552.0 million | $482.0 million (Dec 31, 2006) |
| Cash and Cash Equivalents | $61.5 million | $91.5 million (Dec 31, 2006) |
| Net Assets Per Share | $15.84 | $15.17 (Dec 31, 2006) |
Material Changes vs. Prior Period
- Portfolio Growth: Total investments at fair value increased from $1.24 billion (Dec 31, 2006) to $1.62 billion (June 30, 2007). The number of portfolio companies grew from 60 to 71.
- Revenue Surge: Total investment income increased 72% year-over-year, driven by a larger portfolio size (average investments at fair value rose from $730.5 million to $1.3 billion).
- Expense Increase: Total expenses rose 76% to $43.2 million, primarily due to higher interest expense ($16.1 million vs. $6.5 million) and management fees resulting from increased asset levels and borrowings.
- Realized Losses: The company reported net realized losses of $7.5 million for the six months ended June 30, 2007, compared to net realized gains of $24.5 million in the prior year. The primary driver was an $8.3 million realized loss on the investment in Berkline/Benchcraft Holdings LLC.
- Unrealized Gains: Net unrealized appreciation increased by $20.7 million, reversing prior depreciation on Berkline and recognizing appreciation in Reflexite Corporation and The GSI Group, Inc.
- Capital Raising: The company completed two public add-on offerings in 2007 (February and April), raising approximately $294.4 million in net proceeds, significantly increasing equity capital.
Guidance, Outlook, Risks, and Unusual Items
- Outlook: Management maintains an investment pipeline of approximately $519.0 million and outstanding commitments of $240.0 million as of July 31, 2007. The company expects to syndicate a portion of these commitments.
- Credit Ratings: On July 31, 2007, Moody's assigned a Baa3 issuer rating, and S&P assigned a BBB counterparty credit rating.
- Portfolio Quality: The weighted average investment grade of debt in the portfolio was 3.0. No loans were on non-accrual status as of June 30, 2007. Four companies were graded as "2" (performing below expectations), representing $53.8 million in fair value.
- Interest Rate Risk: Approximately 51% of the portfolio is at variable rates, while 37% is at fixed rates. Borrowings are also primarily variable rate. A 100 basis point increase in rates would increase net income by approximately $2.7 million annually.
- Commitments: The company has $181.4 million in unfunded commitments. $216.2 million of total commitments extend beyond the maturity of the Revolving Credit Facility.
- Unusual Items: The significant realized loss on Berkline/Benchcraft Holdings LLC was a notable negative item offset by unrealized appreciation in other holdings.
Key Facts for Investor Verification
- Dividend Sustainability: Verify the company's ability to maintain its dividend policy ($0.41 per share declared in Q2 2007) given the shift from realized gains to realized losses in the current period.
- Debt Maturity Profile: Review the maturity dates of the $552 million in debt, specifically the CP Funding Facility expiring October 31, 2007, and the Revolving Credit Facility expiring December 28, 2010.
- Valuation Methodology: Confirm the fair value determinations for non-publicly traded securities, which constitute the majority of the portfolio, as these are subject to board discretion and independent review.
- Concentration Risk: Assess the impact of the top holdings (Healthcare Services at 31.7% of net assets) on overall portfolio performance.
- Unfunded Commitments: Monitor the $181.4 million in unfunded commitments and the company's liquidity position to meet these obligations without diluting shareholders or increasing leverage beyond regulatory limits.